Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Academic Article RDF

  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • more...
  • A peptide that antagonizes tcr-mediated reactions with both syngeneic and allogeneic agonists: Functional and structural aspects
  • A peptide-free, liposome-based oligosaccharide vaccine, adjuvanted with a natural killer T cell antigen, generates robust antibody responses
  • A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice
  • A peptidomics strategy to elucidate the proteolytic pathways that inactivate peptide hormones
  • A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity
  • A peptoid antagonist of VEGF receptor 2 recognizes a 'hotspot' in the extracellular domain distinct from the hormone-binding site
  • A PERIOD inhibitor buffer introduces a delay mechanism for CLK/CYC-activated transcription
  • A peripheral and central t-cell antigen recognized by a monoclonal thymocytotoxic autoantibody from new-zealand black mice
  • A periplasmic reducing system protects single cysteine residues from oxidation
  • A permutation test for stabilization of polypeptide helices by sequence-dependent side chain interactions: Characterization of a helix initiation site within the myohemerythrin sequence 76-87
  • A permutational approach toward protein-DNA recognition
  • A persistent RNA-DNA hybrid is formed during transcription at a phylogenetically conserved mitochondrial DNA sequence
  • A perspective on mechanisms of protein tetramer formation
  • A perspective on the structural and functional constraints for immune evasion: insights from influenza virus
  • A PET imaging strategy for interrogating target engagement and oncogene status in pancreatic cancer
  • A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
  • A ph sensitive colorometric assay for the high-throughput screening of enzyme inhibitors and substrates: A case study using kinases
  • A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries
  • A phage display system with unnatural amino acids
  • A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone
  • A pharmacological network for lifespan extension in Caenorhabditis elegans
  • A pharmacophore modeling approach to design new taxol (R) mimics: towards the synthesis of potential anticancer and MDR-reversing agent
  • A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan
  • A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies
  • A phase i clinical trial of the hu14.18-il2 (emd 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: A study of the children's oncology group
  • A phase i/ib trial of murine monoclonal anti-gd2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma - a report of the children's cancer group
  • A phase I/II trial of nimodipine for HIV-related neurologic complications
  • A phase-i study of human mouse chimeric antiganglioside gd2 antibody ch14.18 in patients with neuroblastoma
  • A phase-i study of neuroblastoma with the antiganglioside gd2 antibody 14.G2a
  • A phenotype survey of 36 mutant mouse strains with gene-targeted defects in glycosyltransferases or glycan-binding proteins
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • more...

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support